Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEPHALOTHIN: 52 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
52
Total FAERS Reports
4 (7.7%)
Deaths Reported
14
Hospitalizations
52
As Primary/Secondary Suspect
6
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available

FDA Application: 050482 ·

First Report: 20021218 · Latest Report: 20221231

What Are the Most Common CEPHALOTHIN Side Effects?

#1 Most Reported
Hypotension
8 reports (15.4%)
#2 Most Reported
Anaphylactic shock
7 reports (13.5%)
#3 Most Reported
Bronchospasm
6 reports (11.5%)

All CEPHALOTHIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hypotension 8 15.4% 1 1
Anaphylactic shock 7 13.5% 0 0
Bronchospasm 6 11.5% 1 0
Drug reaction with eosinophilia and systemic symptoms 5 9.6% 0 3
Drug resistance 5 9.6% 1 0
Hypertension 5 9.6% 0 1
Urticaria 5 9.6% 0 0

Who Reports CEPHALOTHIN Side Effects? Age & Gender Data

Gender: 59.6% female, 40.4% male. Average age: 57.2 years. Most reports from: NO. View detailed demographics →

Is CEPHALOTHIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2002 1 0 0
2014 3 0 0
2015 1 0 1
2016 2 1 0
2017 1 0 0
2022 1 0 1

View full timeline →

What Is CEPHALOTHIN Used For?

IndicationReports
Product used for unknown indication 17

Official FDA Label for CEPHALOTHIN

Official prescribing information from the FDA-approved drug label.